The Duke Hemostasis & Thrombosis Center provides a multidisciplinary approach to the diagnosis and management of patients with a wide variety of hemostatic disorders and is a leader in basic research efforts, translational research, and clinical trials in this area. Disorders of particular interest to HTC investigators include antiphospholipid antibody syndrome, heparin-induced thrombocytopenia, and other complex thrombotic disorders. More »